LEQEMBI is a treatment for Alzheimer's Disease that is administered via IV infusion. It targets amyloid beta proteins, which can be be one of the causes of Alzheimer's Disease.

Only a healthcare provider can determine whether LEQEMBI is appropriate for a specific patient. 

Before we make an appointment for a LEQEMBI evaluation for a patient, records will be reviewed to determine if consultation is appropriate.

LEQEMBI is given via IV infusion every two weeks. It is only administered in a healthcare provider's office or in an infusion center.

Duration of treatment depends on each patient's symptoms and tolerance of the medication. You can discuss expected duration of treatment during your LEQEMBI consultation.

You can take a look at LEQEMBI's website, or call our office at 972-433-9100 with any questions!